Introduction
============

Exfoliation syndrome is the most common identifiable cause of open-angle glaucoma worldwide. It is an age-related, generalized disorder of the extracellular matrix that is characterized by the production and progressive accumulation of a fibrillar extracellular material in many ocular tissues \[[@r1]\]. A recent genome-wide association study demonstrated that one intronic single nucleotide polymorphism (SNP, [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241)) and two exonic SNPs ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) \[R141L\] and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) \[G153D\]), which are located in the first exon of the lysyl oxidase like1 (*LOXL1*) gene on chromosome 15q24.1, are highly associated with exfoliation syndrome in Icelandic and Swedish populations while none of these SNPs were associated with primary open-angle glaucoma in either of the two populations \[[@r2]\].

Until now, several lines of studies have reported significant associations of these *LOXL1* SNPs with exfoliation syndrome \[[@r3]-[@r16]\] or the lack of associations of these SNPs with primary open-angle glaucoma \[[@r16]-[@r18]\] in various populations. In these studies, subjects in their 40s and 50s are sometimes recruited as controls. The prevalence of clinical exfoliation syndrome increases with age, particularly after the age of 60 years \[[@r1]\]. However, preclinical exfoliation syndromes in younger generations are able to distinguish from normal subjects until patients become older. Accordingly, the level of statistical significance between exfoliation syndrome and controls could be underestimated in studies that include younger patients in the control group. In this study, we evaluated the association of three *LOXL1* SNPs in Japanese patients with exfoliation syndrome/glaucoma, primary open angle glaucoma, normal tension glaucoma, and cataract. To reduce the chance of misclassifying latent syndromes within the control group, only patients aged 70 years or older were recruited as primary open-angle glaucoma, normal tension glaucoma, or cataract subjects in this study. To the best of our knowledge, this is the first study reporting an association of *LOXL1* SNPs with exfoliation syndrome/glaucoma using age-controlled subjects. This is also the first study reporting the association of *LOXL1* SNPs with normal tension glaucoma.

Methods
=======

Subjects
--------

Three hundred and ninety-three unrelated Japanese subjects presenting exfoliation syndrome without glaucoma (EX), exfoliation syndrome with glaucoma (EG), primary open-angle glaucoma (PG), normal tension glaucoma (NG), and cataract (CT) were recruited at the Shimane University Hospital and Iinan Hospital in Shimane, Japan. This study adhered to the tenets of the Declaration of Helsinki. The research was reviewed and approved by the Institutional Review Boards of both hospitals. Written informed consent was obtained from all of the subjects. All of the subjects underwent a dilated pupil examination of the anterior segments, ocular media, and fundus using a slit-lamp and a funduscope. The subjects with EX and EG exhibited the typical pattern of exfoliation material on the anterior lens surface and/or pupillary margin during slit-lamp examination. The subjects with EG and PG had a history of intraocular pressure (IOP) greater than or equal to 21 mmHg, and the subjects with EX, NG, and CT had a history of IOP never exceeding 20 mmHg. The subjects with PG, NG, and EG presented a typical glaucomatous optic disc cupping or rim thinning and visual field loss. The patients who had a history of IOP greater than or equal to 21 mmHg but no glaucomatous optic disc changes nor visual field loss were assigned as EG in this study. To avoid possible misclassification of latent exfoliation syndromes as PG, NG, or CT, patients younger than 70 years old were not recruited. The number of subjects, each gender, and the mean and range of ages in each group are summarized in [Table 1](#t1){ref-type="table"}.

###### Summary of study populations.

  **Parameter**     **Exfoliation syndrome or glaucoma**   **Primary glaucoma**   **CT**      **p value**                                       
  ----------------- -------------------------------------- ---------------------- ----------- ------------- ----------- ----------- ----------- ------------
  No. of subjects   59                                     83                     142         40            54          94          157         
  Male:Female                                                                                                                                   
  N                 12:47                                  42:41                  54:88       14:26         18:36       32:62       45:112      0.2264\*
  \%                20.3:79.7                              50.6:49:4              50.6:49:4   35.0:65.0     33.3:66.7   34.0:66.0   28.7:71.3   
  Age (years)                                                                                                                                   
  mean±SD           78.2±8.0                               78.8±8.5               78.5±8.2    75.6±5.3      78.3±4.8    77.2±5.1    77.2±5.0    0.1271\*\*
  Range             55--95                                 57--95                 55--95      70--87        70--91      70--91      70--90      

The asterisk and double asterisk indicate that the p values were obtained by Pearson\'s χ^2^test and one-way ANOVA, respectively, among three (EX+EG, PG+NG, and CT) groups. EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open-angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; CT, cataract aged 70 years or older.

DNA genotyping
--------------

Genomic DNA was extracted from the peripheral white blood cells of each subject. Polymerase chain reaction (PCR) was performed using primers designed to amplify the genomic region containing both [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) (forward primer: 5′-AGG TGT ACA GCT TGC TCA ACT C-3′ and reverse primer: 5′-TAG TAC ACG AAA CCC TGG TCG T-3′) or just [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (forward primer: 5′-AGA ATG CAA GAC CTC AGC ATG AG-3′ and reverse primer: 5′-TAG TGG CCA GAG GTC TGC TAA G-3′). The sequence was determined based on the dideoxy terminator method using an ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol. We used SeqScape Software version 2.5 (Applied Biosystems) to analyze the sequence alignment.

Statistical analysis
--------------------

The deviation of the genotype distributions from the Hardy--Weinberg equilibrium was assessed in the case and control samples using [HAPLOVIEW](http://www.broad.mit.edu/mpg/haploview/index.php) version 4.0 \[[@r19]\]. Statistical analysis was performed using [R version 2.6.2](http://www.R-project.org). Fisher's exact test was used to compare the allele or genotype frequencies of each case group with the controls. The odds ratio (OR) and 95% confidence intervals (CIs) were calculated by the logistic regression method. Individual haplotypes and their estimated population frequencies were inferred using [HAPLOVIEW](http://www.broad.mit.edu/mpg/haploview/index.php) version 4.0 \[[@r19]\] with all of the parameters set at the default values.

Results
=======

The allelic and genotypic counts and frequencies of SNPs [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) within *LOXL1* are shown in [Table 2](#t2){ref-type="table"}. The ORs and p values for the allelic and genotypic frequencies of the three SNPs in comparison between the cases (EX, EG, and EX+EG) and controls (CT, PG, NG, and PG+NG) are shown in [Table 3](#t3){ref-type="table"}. In comparison with the CT group, the SNPs showed a significant association with EX, EG, and EX+EG for the T allele of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) at OR=19.71--28.23 and p=1.69x10^−23^-3.00x10^−45^, the G allele of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) at OR=28.21--39.78 and p=1.77x10^−8^-2.42x10^−22^, and the C allele of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) at OR=16.59--23.40 and p=4.79x10^−5^-1.08x10^−9^ ([Table 3](#t3){ref-type="table"}). The genotypes, TT of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) (p=4.11x10^−25^-3.78x10^−43^), GG of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) (p=3.53x10^−11^-2.10x10^−33^), and CC of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (p=1.95x10^−4^-1.07x10^−8^), also showed significant associations with EX, EG, and EX+EG when they were compared to the CT group ([Table 2](#t2){ref-type="table"} and [Table 3](#t3){ref-type="table"}). Significant associations with EX, EG, and EX+EG were detected in comparisons with the primary glaucoma groups (PG, NG, and PG+NG) for the alleles, T of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), G of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), and C of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), as well as the genotypes, TT of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), GG of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), and CC of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241), with the exception of the comparisons between EX, EG, or EX+EG and the PG groups for allelic (OR=4.56--6.43 and p=0.3051--0.0729) and genotypic (p=0.3000--0.0715) frequencies in [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) ([Table 3](#t3){ref-type="table"}).

###### Allelic and genotypic counts and frequencies of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) in exfoliation syndrome/glaucoma (EX, EG, and EX+EG), primary glaucoma (PG, NG, PG+NG), and cataract (CT).

  ** **                                                                 **Exfoliation syndrome or glaucoma**   **Primary glaucoma**                                                                             
  --------------------------------------------------------------------- -------------------------------------- ---------------------- ----- ------- ----- ------- ---- ------- ---- ------- ----- ------- ----- -------
  [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)                                                                                                                                           
  Allele                                                                                                                                                                                                        
  T                                                                     111                                    0.941                  159   0.958   270   0.951   39   0.488   50   0.463   89    0.473   140   0.446
  G                                                                     7                                      0.059                  7     0.042   14    0.049   41   0.513   58   0.537   99    0.527   174   0.554
  Genotype                                                                                                                                                                                                      
  TT                                                                    54                                     0.915                  76    0.916   130   0.916   10   0.25    8    0.148   18    0.192   25    0.159
  TG                                                                    3                                      0.051                  7     0.084   10    0.070   19   0.475   34   0.630   53    0.564   90    0.573
  GG                                                                    2                                      0.034                  0     0       2     0.014   11   0.275   12   0.222   23    0.245   42    0.268
  [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)                                                                                                                                           
  Allele                                                                                                                                                                                                        
  G                                                                     117                                    0.992                  165   0.994   282   0.993   64   0.800   86   0.796   150   0.798   253   0.806
  A                                                                     1                                      0.009                  1     0.006   2     0.007   16   0.200   22   0.204   38    0.202   61    0.194
  Genotype                                                                                                                                                                                                      
  GG                                                                    58                                     0.983                  82    0.988   140   0.986   25   0.625   33   0.611   58    0.617   100   0.637
  AG                                                                    1                                      0.017                  1     0.012   2     0.014   14   0.350   20   0.370   34    0.362   53    0.338
  AA                                                                    0                                      0                      0     0       0     0       1    0.025   1    0.019   2     0.021   4     0.026
  [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241)                                                                                                                                           
  Allele                                                                                                                                                                                                        
  C                                                                     117                                    0.992                  165   0.994   282   0.993   77   0.963   93   0.861   170   0.904   275   0.876
  T                                                                     1                                      0.009                  1     0.006   2     0.007   3    0.038   15   0.139   18    0.096   39    0.124
  Genotype                                                                                                                                                                                                      
  CC                                                                    58                                     0.983                  82    0.988   140   0.986   37   0.925   40   0.741   77    0.819   122   0.777
  CT                                                                    1                                      0.017                  1     0.012   2     0.014   3    0.075   13   0.241   16    0.170   31    0.198
  TT                                                                    0                                      0                      0     0       0     0       0    0       1    0.019   1     0.011   4     0.026

EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; and CT, cataract aged 70 years or older.

###### Odds ratios and p values for allelic and genotypic frequencies of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661), [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) in comparison between cases (EX, EG, and EX+EG) and controls (CT, PG, NG, and PG+NG).

  **Parameter**                                                         **EX**           **EG**           **EX+EG**                                                                                                                                                
  --------------------------------------------------------------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)                                                                                                                                                                                              
  Allele                                                                                                                                                                                                                                                           
  p value                                                               1.69x 10^--23^   3.23x 10^--13^   2.55x 10^--16^   4.08x 10^--19^   5.65x 10^--33^   1.92x 10^--17^   1.32x 10^--21^   4.71x 10^--26^   3.00x 10^--45^   2.61x 10^--20^   4.40x 10^--26^   1.18x 10^--33^
  OR                                                                    19.71            16.67            18.39            17.64            28.23            23.88            26.35            25.27            23.97            20.27            22.37            21.45
  95% CI                                                                8.90--43.67      6.91--40.22      7.84--43.14      7.80--39.88      12.83--62.14     9.96--57.27      11.31--61.41     11.25--56.76     13.40--42.87     10.14--40.56     11.60--43.16     11.67--39.43
  Genotype                                                                                                                                                                                                                                                         
  p value                                                               4.11x 10^--25^   1.16x 10^--11^   1.91x 10^--17^   2.31x 10^--19^   4.80x 10^--32^   2.12x 10^--14^   6.50x 10^--21^   3.42x 10^--24^   3.78x 10^--43^   1.04x 10^--16^   2.74x 10^--25^   3.57x 10^--31^
  [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)                                                                                                                                                                                              
  Allele                                                                                                                                                                                                                                                           
  p value                                                               1.77x 10^--8^    2.10x 10^--33^   2.10x 10^--33^   2.10x 10^--33^   2.42x 10^--22^   6.48x 10^--8^    4.72x 10^--9^    1.23x 10^--10^   3.98x 10^--16^   8.68x 10^--10^   1.47x 10^--11^   1.84x 10^--14^
  OR                                                                    28.21            29.25            29.93            29.64            39.78            41.25            42.21            41.8             34               35.25            36.07            35.72
  95% CI                                                                3.86--205.97     3.79--225.66     3.96--226.36     4.01--219.07     5.46--289--78    5.36--317.49     5.59--318.47     5.67--308.20     8.23--140.45     7.91--157.16     8.31--156.49     8.50--150.11
  Genotype                                                                                                                                                                                                                                                         
  p value                                                               2.10x 10^--33^   2.10x 10^--33^   2.10x 10^--33^   2.10x 10^--33^   3.53x 10^--11^   7.19x 10^--8^    2.88x 10^--9^    1.11x 10^--10^   6.37x 10^--16^   1.20x 10^--9^    1.00x 10^--11^   1.17x 10^--14^
  [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241)                                                                                                                                                                                              
  Allele                                                                                                                                                                                                                                                           
  p value                                                               4.79x 10^--5^    0.3051           1.03x 10^--33^   1.20x 10^--3^    7.87x 10^--7^    0.1022           4.87x 10^--6^    8.28x 10^--5^    1.08x 10^--9^    0.0729           1.52x 10^--7^    3.02x 10^--6^
  OR                                                                    16.59            4.56             18.87            12.39            23.4             6.43             26.61            17.47            20               5.49             22.74            14.93
  95% CI                                                                2.25--122.20     0.47--44.63      2.45--145.49     1.63--94.08      3.18--171.92     0.66--62.81      3.46--204.70     2.31--132.36     4.78--83.62      0.90--33.46      5.11--101.30     3.42--65.14
  Genotype                                                                                                                                                                                                                                                         
  p value                                                               1.95x 10^--4^    0.3              1.59x 10^--4^    2.82x 10^--3^    5.14x 10^--6^    0.1004           7.16x 10^--6^    1.23x 10^--4^    1.07x 10^--8^    0.0715           2.79x 10^--7^    4.71x 10^--6^

OR, odds ratio; CI, confidence interval; NA, not applicable; EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open-angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; and CT, cataract aged 70 years or older. p values were obtained by Fisher\'s exact probability test.

None of the three SNPs showed a significant difference between the EX and EG groups in these allelic or genotypic frequencies ([Table 4](#t4){ref-type="table"}). In addition to this, none of the three SNPs showed significant differences in their allelic or genotypic frequencies in comparisons between the primary glaucoma (PG, NG, or PG+NG) and CT groups or between the PG and NG groups (data not shown), excepted for the allele C of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (p=0.0233) and the genotype CC of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (p=0.0294) in comparison between the PG and NG groups.

###### Odds ratios and p values for three SNPs in comparison between EX and EG.

                                                                        **EX versus EG**                                                                                                                            
  --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- -------------
  [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)   [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)   [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241)   
  Allele                                                                                                                                                                                                            
  p value                                                               0.5829                                                                1                                                                     1
  OR                                                                    1.43                                                                  1.41                                                                  1.41
  95% CI                                                                0.49--4.20                                                            0.09--22.78                                                           0.09--22.78
  Genotype                                                                                                                                                                                                          
  p value                                                               0.2005                                                                1                                                                     1

No significant association was found between EX and EG. OR, odds ratio; CI, confidence interval; EX, exfoliation syndrome; and EG, exfoliation glaucoma. p values were obtained by Fisher\'s exact probability test.

The two SNPs, [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), were in linkage disequilibrium (D'=1). In our study populations, only three of the four possible haplotypes in [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)/[rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) were detected ([Table 5](#t5){ref-type="table"} and [Table 6](#t6){ref-type="table"}). In the comparisons between cases (EX, EG, or EX+EG) and controls (CT+PG+NG), the T and G were significantly associated with EX, EG, and EX+EG, and the G and A had a significant protective effect ([Table 5](#t5){ref-type="table"} and [Table 6](#t6){ref-type="table"}).

###### Counts and frequencies of haplotype [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)/[rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) in cases (EX, EG, and EX+EG) and controls (CT, NG, PG+NG, CT+NG, and CT+PG+NG).

              **Cases**                                                                                                                          
  ----------- --------------- ----------- --------------- -------------- --------------- ----------- --------------- ----------- --------------- -------
  **EX**      **EG**          **EX+EG**                                                                                                          
  **Count**   **Frequency**   **Count**   **Frequency**   **Count**      **Frequency**                                                           
  TG          111             0.941       159             0.958          270             0.951                                                   
  GG          6               0.051       6               0.036          12              0.042                                                   
  GA          1               0.008       1               0.006          2               0.007                                                   
              **Controls**                                                                                                                       
  **CT**      **NG**          **PG+NG**   **CT+NG**       **CT+PG+NG**                                                                           
  **Count**   **Frequency**   **Count**   **Frequency**   **Count**      **Frequency**   **Count**   **Frequency**   **Count**   **Frequency**   
  TG          140             0.443       50              0.463          89              0.473       190             0.448       229             0.454
  GG          115             0.364       36              0.333          61              0.324       151             0.356       176             0.349
  GA          61              0.193       22              0.204          38              0.202       83              0.196       99              0.196

EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; and CT, cataract aged 70 years or older.

###### P values for haplotype [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)/[rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) in comparisons between cases (EX, EG, and EX+EG) and controls (CT, NG, PG+NG, CT+NG, and CT+PG+NG).

                      **EX**                                                                                      
  ------------------- ------------------- ---------------------- ---------------------- ------------------------- --------------
  **Versus** **CT**   **Versus NG**       **Versus** **PG+NG**   **Versus** **CT+NG**   **Versus** **CT+PG+NG**   
  TG                  9.56x10^-21^        NA                     9.56x10^-21^           6.19x10^-17^              1.27x10^-21^
  GG                  9.69x10^-11^        NA                     9.69x10^-11^           1.76x10^-10^              1.43x10^-10^
  GA                  1.01x10^-6^         NA                     1.01x10^-6^            5.63x10^-7^               5.63x10^-7^
                      **EG**                                                                                      
  **Versus** **CT**   **Versus** **NG**   **Versus** **PG+NG**   **Versus** **CT+NG**   **Versus** **CT+PG+NG**   
  TG                  1.83x10^-28^        4.95x10^-21^           3.06x10^-23^           9.77x10^-30^              4.40x10^-20^
  GG                  3.12x10^-15^        2.51x10^-11^           4.82x10^-12^           2.60x10^-15^              3.70x10^-15^
  GA                  5.63x10^-9^         8.10x10^-9^            4.08x10^-9^            3.02x10^-9^               2.36x10^-9^
                      **EX+EG**                                                                                   
  **Versus** **CT**   **Versus** **NG**   **Versus** **PG+NG**   **Versus** **CT+NG**   **Versus** **CT+PG+NG**   
  TG                  1.23x10^-40^        7.84x10^-29^           1.24x10^-32^           5.89x10^-43^              8.27x10^-44^
  GG                  5.93x10^-22^        4.01x10^-15^           1.03x10^-16^           2.39x10^-22^              2.83x10^-22^
  GA                  1.17x10^-13^        3.98x10^-13^           9.33x10^-14^           3.68x10^-14^              2.25x10^-14^

Significant association was found between cases and controls. EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; and CT, cataract aged 70 years or older. NA, not available due to a small number of samples.

Discussion
==========

Based on this study among 393 elderly Japanese patients with exfoliation syndrome, exfoliation glaucoma, primary open-angle glaucoma, and cataract, we confirmed the findings of Thorleifsson and colleagues \[[@r2]\] that three SNPs within *LOXL1* are strongly associated with exfoliation syndrome and glaucoma. In addition to the original study in Icelandic and Swedish populations, allele G of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) has been consistently suggested as a risk--associated allele of exfoliation syndrome/glaucoma in five studies from the United States \[[@r3]-[@r7]\], two studies from Europe \[[@r8],[@r9]\], one study from India \[[@r10]\], one study from Australia \[[@r11]\], and six studies including this one from Japan \[[@r12]-[@r16]\]. In this study, we found that allele T of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) is associated with exfoliation syndrome/glaucoma, which is consistent with other studies in the Japanese population \[[@r12]-[@r16]\], while allele G is reported to be risk-associated in studies from other countries \[[@r2]-[@r4],[@r6]-[@r11]\]. We also found that allele C of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) is associated with exfoliation syndrome/glaucoma, which is consistent with one study from Japan \[[@r13]\], while allele T is risk-associated in other populations \[[@r2],[@r4],[@r5],[@r7],[@r8]\]. Allelic frequencies of the three SNPs reported in previous studies and the current study are summarized in [Figure 1](#f1){ref-type="fig"}. These results suggest a possibility that the missense changes in *LOXL1* are not actually causative but mark a haplotype that carries variants that may indeed be causative.

![Allelic frequencies of the three SNPs reported in previous studies and the current study. Allelic frequencies of three SNPs in cases (exfoliation syndrome and exfoliation glaucoma) and controls (cataract or normal population) that have been reported in literatures are summarized.](mv-v14-1898-f1){#f1}

In this study, none of the SNPs exhibited significant differences in their allelic and genotypic frequencies between exfoliation syndrome and glaucoma, suggesting that these SNPs are associated with exfoliation glaucoma through their association with exfoliation syndrome as reported previously \[[@r2]\]. Accordingly, our data suggest that additional genetic or environmental risk factors are associated with the development of exfoliation glaucoma among exfoliation syndrome patients. Further study is required to clarify these risks.

This study revealed extremely high ORs and significant p values for the three SNPs in the comparisons between the exfoliation syndrome/glaucoma groups and cataract groups. Only patients aged 70 years or older were recruited as control subjects in this study, enabling us to reduce the chance of misclassifying latent or preclinical exfoliation syndromes into the control group. Accordingly, the inclusion criteria of the control group might contribute to the extremely significant association of the *LOXL1* SNPs with exfoliation syndrome in this study. In contrast, the significance of the association of the SNPs with exfoliation syndrome/glaucoma was relatively low when the PG group was used as a control comparison compared to when the NG or CT groups were used as control comparisons. Although the level of significance was relatively low, we found differences in frequencies between PG and NG for allele C of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (p=0.0233) and the genotype CC of [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) (p=0.0294). These may suggest the possible inclusion of late onset exfoliation syndrome in the PG group. Previously, a lack of association between *LOXL1* polymorphisms and primary open-angle glaucoma or primary angle-closure glaucoma were reported in Caucasian, African American, Ghanaian, and Indian populations \[[@r17],[@r18]\]. We did not find any significant associations between any of the three SNPs with primary open-angle glaucoma, reconfirming the previous observations in our Japanese population. Most recently, one study from Japan reported a lack of association between *LOXL1* polymorphisms and primary open-angle glaucoma in two of three SNPs (e.g., [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)) \[[@r16]\]. In addition to this, the current study suggests a lack of association between [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) and primary open-angle glaucoma as well as a lack of association between any of the three SNPs with normal tension glaucoma.

In summary, we have demonstrated significant associations of *LOXL1* variants with Japanese patients who have exfoliation syndrome/glaucoma. Compared to other populations, the risk alleles in [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs2165241](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2165241) are unique in this population. The *LOXL1* association of exfoliation glaucoma is through the association of exfoliation syndrome. *LOXL1* lacked any association with primary open-angle glaucoma or normal tension glaucoma in this population. Additional genetic or environmental risk factors other than *LOXL1* are likely to be associated with an increase in exfoliation glaucoma among exfoliation syndrome patients.
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